Gene · 1048
Papers3,868
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 3,868
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ultrasound and clinicopathological characteristics of breast cancer for predicting axillary lymph node metastasis. | Clin Hemorheol Microcirc | 2023 | 37694357 | PubTator, text mining | PubMed |
| CEACAM expression in an in-vitro prostatitis model. | Front Immunol | 2023 | 37691945 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing captures patient-level heterogeneity and associated molecular phenotypes in breast cancer pleural effusions. | Clin Transl Med | 2023 | 37691350 | PubTator, text mining | PubMed |
| Metastasis organotropism in colorectal cancer: advancing toward innovative therapies. | J Transl Med | 2023 | 37689664 | PubTator, text mining | PubMed |
| Differentially Expressed Genes, miRNAs and Network Models: A Strategy to Shed Light on Molecular Interactions Driving HNSCC Tumorigenesis. | Cancers (Basel) | 2023 | 37686696 | PubTator, text mining | PubMed |
| MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy. | Int J Mol Sci | 2023 | 37686110 | PubTator, text mining | PubMed |
| Molecular analysis with pancreaseq® in evaluation and management of pancreatic cysts: A cohort of 28 patients. | Cytojournal | 2023 | 37681071 | PubTator, text mining | PubMed |
| Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults. | Eur J Epidemiol | 2023 | 37676424 | PubTator, text mining | PubMed |
| Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative review. | Ann Transl Med | 2023 | 37675321 | PubTator, text mining | PubMed |
| Holistic Understanding of the Role of Carbohydrate Antigen 19-9 in Pancreatic Cancer Screening, Early Diagnosis, and Prognosis: A Systematic Review. | Cureus | 2023 | 37671217 | PubTator, text mining | PubMed |
| Molecular Targets of Aptamers in Gastrointestinal Cancers: Cancer Detection, Therapeutic Applications, and Associated Mechanisms. | J Cancer | 2023 | 37670975 | PubTator, text mining | PubMed |
| Function and clinical application of exosome-how to improve tumor immunotherapy? | Front Cell Dev Biol | 2023 | 37670933 | PubTator, text mining | PubMed |
| Effect of chimeric antigen receptor T cells against protease-activated receptor 1 for treating pancreatic cancer. | BMC Med | 2023 | 37667257 | PubTator, text mining | PubMed |
| Predicting Response to Antibody Drug Conjugates: A Focus on Antigens' Targetability. | Oncologist | 2023 | 37665782 | PubTator, text mining | PubMed |
| Targeted splicing therapy: new strategies for colorectal cancer. | Front Oncol | 2023 | 37664052 | PubTator, text mining | PubMed |
| Editorial: Tumor adaptation to cellular stresses: mechanisms, biomarkers and therapeutic opportunities. | Front Med (Lausanne) | 2023 | 37663659 | PubTator, text mining | PubMed |
| Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications. | Front Immunol | 2023 | 37662949 | PubTator, text mining | PubMed |
| Delineating intra-tumoral heterogeneity and tumor evolution in breast cancer using precision-based approaches. | Front Genet | 2023 | 37662839 | PubTator, text mining | PubMed |
| The search for therapeutic targets in lung cancer: Preclinical and human studies of carcinoembryonic antigen-related cell adhesion molecule 5 expression and its associated molecular landscape. | Lung Cancer | 2023 | 37660479 | PubTator, text mining | PubMed |
| Advances in immunotherapy for triple-negative breast cancer. | Mol Cancer | 2023 | 37660039 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1048/papers?page=20